Effects of Smoking Marijuana: Immediate and with Daily Use

The effects of smoking marijuana depend on frequency: a single session produces immediate effects that fade within hours, while daily smoking over years leads to chronic effects. Daily means at least 20 days per month for over a year in studies, and with this pattern three effects have the strongest evidence: chronic bronchitis, psychosis (especially in the heaviest users), and low newborn birth weight. Marijuana smoked daily for years leaves a mark on several organ systems, but the extent depends on four factors: age of initiation, frequency, THC content, and method of administration. The 2017 National Academies of Sciences, Engineering, and Medicine report, the broadest contemporary review, assigns decisive or significant evidence status to only some effects. This article organizes what is known today about neurological, psychiatric, cardiovascular, respiratory, and hormonal consequences of chronic use, where science ends and journalism begins, and where to seek help for addiction in Poland.

KEY INFORMATION
• Among adults who used marijuana in the past year, nearly 3 in 10 met criteria for cannabis use disorder (Hasin et al., 2015).
• For the heaviest use, the odds ratio for psychosis is 3.90 (Marconi et al., 2016).
• Within an hour after smoking, heart attack risk increases 4.8-fold (Mittleman et al., 2001).
• After about 4 weeks of abstinence, CB1 receptors return to normal (Hirvonen et al., 2012).

What does “long-term” marijuana use mean scientifically?

In epidemiological literature, long-term use means a daily or almost daily pattern, i.e., at least 20 days per month, maintained for more than a year. This operational threshold separates occasional recreational use from a pattern with measurable health harms. Most sections below concern this second group, but effects of single sessions and occasional smoking have their own sections immediately after discussing evidence.

The distinction is not formal. The risk profile differs for someone smoking a joint once a month, a patient vaporizing medical cannabis under doctor supervision, and a long-term user of high-potency concentrates. Cohort studies describing harms mainly recruited the third group, so applying their conclusions to occasional use overestimates risk.

The patterns most burdensome in literature can be summarized in one list.

The medical pattern assumes known dose, defined indication, medical monitoring, and usually shorter time horizon. The recreational pattern in chronic users is lack of titration, self-selection of strains, and years of unsupervised exposure. The molecule acts the same, but context changes risk profile.

How to read scientific evidence on marijuana effects?

Statements like “studies prove” or “science does not confirm” are useless here because they blur the difference between strong evidence and suggestion. The 2017 National Academies report solved this differently than typical reviews: instead of issuing verdicts, it assigned each health effect a level of evidence certainty and consistently adhered to it.

There are five levels, from decisive and significant, through moderate and limited, to no or insufficient evidence. The highest category means several independent high-quality studies with consistent results and reasonable exclusion of alternative explanations. The lowest does not mean no effect; it means no one has properly measured it yet, which is a very different statement and often mistaken for exoneration.

This gradation explains why a reliable text on marijuana must sound uneven. The link between chronic smoking and bronchitis symptoms stands at a different evidence level than effects on testosterone. When an article presents both in the same tone as established facts, it usually does not distinguish these levels or deliberately blurs them. In the following sections, each effect includes indication of the evidence base and where the strength ends.

What are the effects of smoking marijuana immediately and the next day?

Immediately after smoking, heart rate accelerates, short-term memory, attention, and coordination weaken, and at higher doses anxiety or panic attacks may occur. After inhalation, these effects usually fade within two to three hours. What remains the next day is known mainly indirectly, as few studies measure the “day after” alone.

The cannabinoid pharmacology review lists acute adverse effects including increased heart rate, blood pressure changes, anxiety, and panic attacks, describing inhalation effects as rising over 15-30 minutes and fading within 2-3 hours (Grotenhermen, 2003). The 2017 National Academies report assesses moderate evidence that fresh use impairs learning, memory, and attention, and significant evidence linking cannabis to traffic accidents. Heart attack risk in the first hour after smoking is discussed below in the heart section.

The most on the next day comes from a meta-analysis of 69 studies in adolescents and young adults. Frequent or heavy users had slightly worse cognitive test results, but in 15 studies requiring over 72 hours abstinence before testing, the difference ceased to be significant (Scott et al., 2018). Some worse results in days after use are thus due to fresh exposure or withdrawal, not permanent change.

Does smoking once a week or once a month cause harm?

Occasional smoking did not worsen lung function in studies, but immediate effects occur with every use. In a 20-year observation of 5115 adults, among whom marijuana smoking was usually rare (median two to three times per month), occasional and low cumulative exposure was not associated with worse lung function (Pletcher et al., 2012). Details of this study are below in the lungs section. A frequency threshold also appears in semen: smoking more than once a week was linked to 28% lower sperm concentration (Gundersen et al., 2015), discussed in the hormones section.

Rare smoking does not remove the risk that appears with every session. In the heart study described below, heart attack risk in the hour after smoking was 4.8 times baseline and declined quickly (Mittleman et al., 2001), and the National Academies report rates evidence for such triggering as limited. The link to traffic accidents, rated significant by National Academies, also arises from post-use state, not monthly session count.

If you smoke occasionally, most risk is reduced by the Lower-Risk Cannabis Use Guidelines described below: late start, infrequent use, non-smoking forms, and no driving after use. The same guidelines recommend total abstinence for people with psychosis or addiction history and pregnant women, regardless of frequency.

How does long-term marijuana use affect memory and cognitive functions?

Chronic marijuana use is associated with worse performance in working memory, attention, and executive function tests. The review by Crean et al. (2011) describes deficits in planning, organization, problem-solving, and decision-making, whose severity depends on quantity, recency, age of initiation, and duration. The same review notes a practical effect: people with executive dysfunction learn skills needed to quit less well, increasing relapse risk.

The brain matures until about age 25, with the prefrontal cortex, responsible for impulse control and planning, finishing last. THC exposure during intense neuroplasticity acts on a different substrate than in adults. Thus cognitive effects in adolescents differ from those starting after their twenties.

The most cited evidence for persistence is the Dunedin study, published by Meier et al. in PNAS 2012. A cohort of 1037 New Zealanders was studied from birth to age 38, with neuropsychological tests at 13 (pre-initiation) and repeated two decades later. Chronic use was linked to declines in many functional domains, even after adjusting for years of education, concentrated in those who started as teens. In this group, cessation did not fully restore baseline levels.

The result sparked methodological debate. Reanalysis by Rogeberg (PNAS, 2013) suggested part of the effect may be socioeconomic status, and later twin cohorts did not fully replicate it. The practical takeaway remains: starting before 18 is inadvisable. For what translates to permanent neuron damage and what does not, see the separate text on does marijuana kill brain cells.

Does long-term marijuana smoking increase heart attack risk?

Yes, at least in the short window after inhalation. The study by Mittleman et al. (Circulation, 2001) included 3882 myocardial infarction patients and compared reported marijuana use in the hour before symptoms with expected frequency. Heart attack risk was elevated 4.8-fold in this window, with confidence interval 2.4 to 9.5, and declined quickly. Authors call marijuana smoking a rare but real trigger.

The mechanism is well described. THC stimulates CB1 receptors in the peripheral nervous system, increasing sympathetic tone, heart rate, and blood pressure. The vascular-cardiac response can be biphasic: tachycardia and hypertension in the first minutes, orthostatic hypotension after half an hour. In most young healthy people, these changes cause no serious problems, though isolated infarcts and strokes have been reported, and in heart disease patients risk is increased (Jones, 2002).

Stroke is a separate issue. The prospective study by Wolff et al. (2011) described multifocal intracranial artery vasospasm in young adults after ischemic stroke linked to cannabis use. This is not a meta-analysis and cannot estimate population risk but indicates a vascular mechanism distinct from that causing infarction.

A 2023 American Heart Association conference report, based on data from 157,000 participants in the All of Us program, linked daily marijuana use to higher heart failure risk. This is a conference abstract, not peer-reviewed, so treat as a signal, not a conclusion. Groups for whom this signal matters most are described in the text on side effects of cannabis abuse.

How does chronic marijuana use affect mental health?

Daily use of high-THC strains increases psychosis risk, with a dose-dependent effect. The meta-analysis by Marconi et al. (Schizophrenia Bulletin, 2016) included 10 studies and 66,816 people. Logistic regression gave an odds ratio of 3.90 (CI 2.84 to 5.34) for schizophrenia and other psychotic disorders in the heaviest users versus non-users. Authors emphasize dose-response in all included studies but caution this does not prove causality.

Sensitivity is uneven. The study by Caspi et al. (Biological Psychiatry, 2005) showed a functional COMT gene polymorphism modifies adolescent cannabis use impact on adult psychosis. Valine allele carriers were most prone to psychotic symptoms and schizophrenia-like disorder, while methionine homozygotes showed no such effect. This is gene-environment interaction, not determinism.

Mood disorders look separate. The meta-analysis by Gobbi et al. (JAMA Psychiatry, 2019) included 11 studies and 23,317 people using cannabis before age 18. Odds ratios were 1.37 for depression in young adulthood, 1.50 for suicidal thoughts, and 3.46 for suicide attempts. The anxiety result, 1.18, was not statistically significant, so repeated claims of “increased anxiety risk” lack support here. Authors note individual risk remains moderate to low but translates to many people due to prevalence. A broader review is in the text on marijuana’s impact on mental health.

How does long-term marijuana smoking affect women outside pregnancy?

Outside pregnancy and fertility, evidence is weaker than for men, as women were a minority in studies and results rarely sex-disaggregated. What can be said concerns three areas: menstrual cycle, addiction risk, and heart disease.

For the cycle, the signal is weak: in the prospective study by Mumford et al., described below in hormones, the link to anovulation was called suggestive but imprecise, as confidence intervals included no effect. Addiction shows a phenomenon called telescoping: in a study of 271 addiction treatment patients, women addicted to cannabis entered treatment after shorter regular use than men, and women reported more severe psychological, health, and occupational complications (Hernandez-Avila et al., 2004). For heart, risk was described for the whole population with no basis to consider women less vulnerable.

The honest conclusion: no evidence that long-term smoking is safer for women, and for some effects simply unknown as no one measured separately.

What is cannabis use disorder and how to recognize addiction?

Cannabis use disorder is a DSM-5 diagnosis. Its scale in the population is measured. The study by Hasin et al. (Am J Psychiatry, 2016), based on interviews with 36,309 US adults in NESARC-III, found DSM-5 disorder prevalence of 2.5% in the past 12 months and 6.3% lifetime. Those diagnosed used marijuana on average 225 days per year.

Another picture emerges when recalculated among users only. Analysis by Hasin et al. (JAMA Psychiatry, 2015) showed that in 2012-2013, 30.6% of past-year users met disorder criteria, down from 35.6% a decade earlier. The percentage among users fell, but the number diagnosed rose as users increased. This distinction is important: risk per user did not increase, user numbers did.

Diagnosis requires meeting 2 of 11 criteria in the past 12 months; number determines severity.

Cannabis withdrawal syndrome entered DSM-5 as a separate entity. Symptoms include irritability, anxiety, sleep disturbances, decreased appetite, and abdominal complaints. They are milder than opioids but can impair functioning enough to cause relapse. It is important to separate two things often conflated: the time THC metabolites remain detectable and the duration of withdrawal symptoms. These are different clocks; only the latter relates to patient well-being.

What happens after cessation and how long symptoms last is detailed in the text on marijuana withdrawal time.

What is cannabinoid hyperemesis syndrome?

It is a syndrome of cyclic vomiting, nausea, and abdominal pain in chronic cannabis users, resolving after cessation. The first case series was described by Allen et al. (Gut, 2004) from South Australia. They identified 19 patients with chronic cannabis use and cyclic vomiting, and after exclusions described nine cases plus one previously published.

The strength lies in the dependency pattern. All patients had chronic cannabis use preceding vomiting onset. Cessation stopped the illness in seven cases. Three did not maintain abstinence and had relapses. Three who resumed use after abstinence relapsed again; two of these stopped again and remained well. This stop-use-return-use-stop pattern is the strongest argument for causality from a case series.

A novel observation was bathing behavior. Nine of ten patients exhibited prolonged hot water bathing during exacerbations, which relieved symptoms. This symptom is so characteristic it guides diagnosis, though remember this is a small sample of ten, not a large cohort.

In practice, the syndrome is often mistaken for cyclic vomiting of other causes, acute gastroenteritis, or obstruction. Diagnosis is by exclusion and response to cannabis cessation. Treatment of exacerbations includes hydration and antiemetics, but permanent solution is abstinence.

Does long-term marijuana smoking cause lung cancer and bronchitis?

Bronchitis yes, lung cancer not proven. The review by Tashkin (Annals of the American Thoracic Society, 2013) summarizes three decades of research cautiously. Regular marijuana smoking causes visible and microscopic damage to large airways, consistently linked to chronic bronchitis symptoms that resolve after cessation.

Lung function is different. The habit alone does not lead, according to this review, to significant abnormalities in function tests, except possible increased lung volume and slight airway resistance increase of unclear clinical meaning. No link to chronic obstructive pulmonary disease was established. This is confirmed by the long CARDIA study by Pletcher et al. (JAMA, 2012), which measured spirometry over 20 years in 5115 people. Occasional and low cumulative marijuana exposure was not associated with worse lung function, and at highest exposures the relationship flattened or reversed.

Lung cancer is a separate matter. Cannabis smoke contains carcinogens and cocarcinogens, but well-designed epidemiological studies do not indicate increased lung or upper airway cancer risk with light and moderate use. For heavy, long-term use, evidence is mixed. Tashkin concludes the overall evidence points to much lower pulmonary complication risk than tobacco, which is not the same as no risk.

Administration form changes exposure. Vaporization limits inhalation of pyrolysis products, and oral forms bypass airways entirely, introducing other issues: delayed onset and harder dose titration.

How does marijuana affect sex hormones and fertility?

The best described data concern semen. The study by Gundersen et al. (American Journal of Epidemiology, 2015) included 1215 young Danish men aged 18-28 presenting for mandatory military examination. Participants provided semen and blood samples and answered questions about marijuana use in the past three months. 45% reported use in that period.

Results depended on frequency. Smoking more than once a week was linked to 28% lower sperm concentration and 29% lower total sperm count after adjustment for confounders. Combining this pattern with other recreational substances lowered concentration by 52% and total count by 55%. Confidence intervals in these analyses approached zero, so precision is moderate.

Testosterone deserves attention, as the common narrative is opposite to the result. Marijuana smokers had higher testosterone levels, similar to cigarette smokers. The claim that chronic cannabis use lowers testosterone by about 15% is unsupported by this study and should not be repeated as fact.

Data for women are scarcer. The prospective study by Mumford et al. (Human Reproduction, 2021) included 1228 women with miscarriage history trying to conceive, measuring THC metabolites in urine rather than relying solely on self-report. Preconception cannabis use was linked to reduced fertility despite more frequent intercourse. The signal for anovulation was described as suggestive but imprecise, as confidence intervals included no effect. This supports caution when trying to conceive rather than alarm.

What are the consequences of marijuana use during pregnancy and breastfeeding?

The American College of Obstetricians and Gynecologists recommends pregnant and planning women stop marijuana, including medicinal use, and advises against use during breastfeeding due to insufficient infant data (ACOG, 2017). THC crosses the placental barrier and acts on the developing fetal endocannabinoid system, involved in neuron migration and synapse formation. This mechanism makes exposure in this window different from any other life stage.

Obstetric outcomes repeatedly show two: lower birth weight and shorter pregnancy duration. A meta-analysis of 16 studies and 59,138 patients found pregnancy exposure doubled risk of birth weight under 2500 g and increased preterm birth risk by 28% (Marchand et al., 2022). The 2017 National Academies report rates evidence linking smoking in pregnancy to lower birth weight as significant, the second of five evidence levels used.

Long-term effects are harder to measure, requiring years of child observation and separating THC impact from family environment. The same report rated evidence for long-term child effects, including cognitive and school outcomes, as insufficient, leaving this open.

THC is lipophilic, accumulates in fat tissue, and passes into breast milk, persisting longer than in plasma. Pediatric societies thus advise against cannabis use during lactation. It is worth debunking reasoning sometimes heard in clinics: marijuana as a natural remedy for morning sickness, safer than medications. This is wrong. Antiemetics used in pregnancy have known safety profiles, while cannabis exposure is linked to lower birth weight and more preterm births.

Does medical marijuana carry the same risks as recreational?

The molecule is the same, context different, and context determines the balance. Medical marijuana patients know THC and CBD content, dose in milligrams, monitor symptoms, and undergo periodic medical evaluation. These conditions reduce risk of developing use disorder and acute psychiatric complications by removing two strongest recreational pattern factors: lack of titration and lack of supervision.

In Poland, medical marijuana has been available since 2017 on Rpw prescription. The prescription requires diagnostic justification, and the product is dispensed through pharmacies supplied by pharmaceutical wholesalers. Clinically, it is used for chronic pain, especially neuropathic, spasticity in multiple sclerosis, refractory epilepsy, and cancer-related anorexia.

A better profile does not mean no contraindications. People under 25, patients with psychosis history, pregnant and breastfeeding women, and those with cardiovascular disease remain groups where risk outweighs benefit even with prescription use. Administration route matters: vaporizing flower burdens airways less than smoking, and oral preparations bypass them entirely.

It is useful to separate three legal categories often conflated in conversation. Medical marijuana is an Rpw prescription drug. Cannabis herb above 0.3% THC is a controlled substance whose possession is punishable. Hemp products below this threshold, e.g., CBD oils, are legal and not subject to controlled substance regulations.

Which individual factors most increase risk?

Five factors most strongly modify health risk, and their effects add up. The strongest single factor is age of initiation. The brain matures until about 25, so exposure before 18 hits a different biological substrate, and the Dunedin study observed a decline in this group that cessation did not fully reverse.

The second factor is genetic background. The COMT polymorphism modifies sensitivity to THC’s psychotomimetic effects, as shown by Caspi’s study. People with family history of schizophrenia or addiction have higher risk regardless of use pattern, the strongest argument for advising against cannabis in this group.

The third, fourth, and fifth are frequency, THC dose, and administration route. Daily use burdens more than occasional. High-THC strains and concentrates carry higher psychosis risk than traditional flower, directly from the dose-response relationship described by Marconi. Smoking with tobacco is the worst form, adding respiratory and cardiovascular risks of tobacco and nicotine addiction.

The hierarchy has practical meaning. Age of initiation acts as a multiplier for all other factors, so a teenager using daily strong concentrates has a qualitatively different risk profile than an adult occasionally using mild flower. Health education that does not show this gradient loses credibility for both.

Are the effects of smoking marijuana reversible?

Largely yes. CB1 receptors, reduced in daily smokers, return to normal after about four weeks of abstinence, and in studies with at least 25 days break, cognitive test differences vanish. Possible exception is those who started as teens and used for years.

Receptor measurement comes from positron emission studies: daily smokers had lower CB1 receptor density in cortex, which returned to normal after about four weeks of documented abstinence (Hirvonen et al., 2012). A meta-analysis of 13 studies with at least 25 days abstinence before testing found no differences in overall cognitive function or any of eight domains (Schreiner and Dunn, 2012). Chronic bronchitis symptoms resolve after quitting, as per Tashkin’s review, described in the lungs section.

The Dunedin study, described in the memory section, differs: those who started as teens and used chronically did not fully regain baseline levels after cessation, though this result is disputed. Other studies found cognitive test differences ceased after over 72 hours abstinence (Scott et al., 2018).

How to reduce risk according to Lower-Risk Cannabis Use Guidelines?

The guidelines by Fischer et al. (American Journal of Public Health, 2017) are evidence-based recommendations for people who have already decided to use cannabis. Their pragmatic goal is harm reduction, not encouragement. The structure is analogous to alcohol guidelines and should be read similarly.

1. The most effective way to avoid risk is abstinence, especially for youth and high-risk groups.
2. Delay initiation as long as possible; the most pronounced harms are linked to starting before age 16.
3. Choose products with lower THC and higher CBD, and avoid concentrates.
4. Do not use synthetic cannabinoids: they cause much more severe acute adverse effects, including deaths.
5. Prefer non-smoking forms: vaporizing flower, oral preparations, sublingual tinctures.
6. Avoid deep inhalations and breath-holding, as they increase carcinogen exposure.
7. Limit frequency to occasional, i.e., a few times per month, not daily.
8. Do not drive or operate machinery under the influence.
9. Do not use at all if prone to psychosis or addiction or with family history, and during pregnancy.
10. Avoid combining risk factors above, e.g., early start with frequent use of high-THC products.

In Poland, these recommendations are informational only, as possession and use remain illegal. This does not make them useless. Patients admitting use to doctors need concrete harm reduction advice more than moralizing, and distinctions between flower, concentrate, and oral preparations are often new to them.

Where to seek help for marijuana addiction in Poland?

Suspected cannabis use disorder treatment includes psychiatric consultation, psychotherapy, and in severe cases inpatient treatment. Most evidence supports cognitive-behavioral therapy and motivational interviewing, often supplemented by reinforcement systems for maintained abstinence.

MONAR Association runs a network of inpatient centers and outpatient clinics in Poland offering free long-term programs. The National Health Fund (NFZ) also funds addiction treatment clinics, day and full-time wards, and outpatient care. Initial contact with addiction clinics does not require referral, meaning one can call and arrange independently.

For those not ready for a visit, phone lines serve as entry points. Free numbers include the Child and Youth Helpline 116 111 (24/7), Anti-Drug Helpline 800 199 990, Adult Mental Health Crisis Support 800 70 2222, and Crisis Helpline 116 123. For immediate life threats, suicidal thoughts, acute psychosis, or poisoning, the correct number is 112.

Conversations with a close user have better chances if starting with specific observations rather than labels. Saying someone stopped training and sleeps until noon opens dialogue. Saying they are addicted usually closes it. Diagnosis belongs to specialists, not family.

What is the legal status of marijuana in Poland?

Possession, cultivation, and trade of cannabis herb other than fiber hemp remain illegal in Poland under the Act of July 29, 2005 on counteracting drug addiction, consolidated text Dz.U. 2023 item 1939. Possession is punishable by up to 3 years imprisonment, harsher for large amounts. Article 62a allows case dismissal for small amounts for personal use if punishment would be inappropriate due to circumstances and social harm degree.

The threshold between fiber hemp and other cannabis herb is 0.3%. Two things are often confused here. First, it is calculated as the sum of delta-9-THC and tetrahydrocannabinolic acid (THCA), rounded to one decimal place, not delta-9-THC alone. This affects lab results. Second, the basis is a national provision, Article 4 point 5 of the mentioned act as amended by the March 24, 2022 act (Dz.U. 2022 item 763), effective May 7, 2022. The national threshold corresponds to the EU threshold in Regulation (EU) 2021/2115 but does not derive from it. The earlier EU threshold of 0.2% came from repealed Regulation 1307/2013.

Medical marijuana has been legally available since 2017 only on Rpw prescription and is not reimbursed. Hemp products below 0.3%, including CBD oils, are legal. Cannabidiol itself is not listed in any controlled substance schedules, and the WHO ECDD 2018 report rated its safety profile as good.

Separately on semi-synthetic substances, as this topic recurs in questions. HHC is a controlled substance in Poland, and its trade and possession outside the act’s provisions remain prohibited. Changes in schedules concerned classification, not legalization.

What to remember about long-term marijuana effects?

Risks are real but unevenly distributed, and not every claim circulating online is supported by research. The best documented harms are chronic bronchitis symptoms in smokers, cannabis use disorder in some regular users, dose-dependent psychosis risk, and effects on the developing adolescent brain. Among adults who used marijuana in the past year, nearly three in ten met use disorder criteria.

Most vulnerable groups can be precisely identified: those starting before 18, pregnant and breastfeeding women, patients with psychosis history, and those with cardiovascular disease. For them, marijuana remains contraindicated even medically, though medical supervision shifts the balance toward benefit.

Regarding reversibility, the picture is moderately optimistic for adults and clearly worse for those who started as teens. The Dunedin study did not observe full return to baseline after cessation in the latter. Cannabis use disorder is effectively treated with cognitive-behavioral therapy and motivational interviewing, and in Poland access does not require referral.

Three claims should be set aside as false or unconfirmed: that marijuana lowers testosterone by about 15%, that it clearly increases anxiety risk in young adults, and that smoking cannabis has a proven link to lung cancer. The first is opposite to the cited study’s result, the second was not statistically significant, and the third remains unresolved. A broader guide on marijuana organizes other topics.

Frequently Asked Questions

Does long-term marijuana smoking permanently damage memory?

In adults, usually not. The review by Crean et al. from 2011 describes deficits in working memory and executive functions, whose severity depends on quantity, recency, and duration. Persistence was mainly observed in those who started before age 18.

What is the real risk of psychosis after chronic marijuana use?

The meta-analysis by Marconi et al. from 2016, covering 10 studies and 66,816 people, gave an odds ratio of 3.90 for the heaviest users versus non-users. Risk increases with dose and is higher in carriers of the valine allele of the COMT gene and people with family history of schizophrenia.

Does marijuana really cause addiction?

Yes. According to Hasin et al. from 2016, cannabis use disorder prevalence is 2.5% annually and 6.3% lifetime in US adults. Among past-year users, the DSM-IV disorder rate reached 30.6% (Hasin et al., 2015).

Does smoking marijuana cause lung cancer?

Evidence is limited and inconclusive. The review by Tashkin from 2013 does not confirm increased lung or upper airway cancer risk with light and moderate use, and for heavy use evidence is mixed. Chronic bronchitis symptoms occur and resolve after cessation.

How long do marijuana withdrawal symptoms last?

Cannabis withdrawal syndrome includes irritability, anxiety, sleep disturbances, decreased appetite, and abdominal complaints. Symptoms are milder than opioids but can impair functioning enough to cause relapse. It is one of eleven DSM-5 diagnostic criteria groups.

Is marijuana dangerous during pregnancy?

Yes. The American College of Obstetricians and Gynecologists recommends cessation during pregnancy, including medicinal use, and advises against use during breastfeeding (ACOG, 2017). The 2017 National Academies report rates significant evidence linking smoking in pregnancy to lower newborn birth weight.

Are the effects of smoking marijuana reversible?

Largely yes. In daily smokers, CB1 receptor density returned to normal after about four weeks of abstinence (Hirvonen et al., 2012), and in studies with at least 25 days abstinence, cognitive test results did not differ from non-users (Schreiner and Dunn, 2012). Bronchitis symptoms resolve after quitting.

Where to seek help for marijuana addiction in Poland?

Free help is offered by MONAR Association centers and clinics and addiction treatment clinics funded by NFZ, where initial contact does not require referral. Free hotlines also operate: 116 111 for youth, 800 199 990 for addiction issues, and 112 for life-threatening emergencies.

If you want to reduce exposure to combustion products per Fischer’s fifth recommendation, heating equipment instead of smoking is available in the vaporizers category.

This article is informational and educational and does not constitute medical advice. Before starting cannabis or CBD for therapeutic purposes, consult a doctor, especially if taking other medications, pregnant, or breastfeeding.

Author: Michał Waluk · Published: 2026-05-11 · Updated: 2026-09-23